The U.S. Food and Drug Administration (FDA) has approved an intravenous form of Uptravi (selexipag) — one infused directly into the…
Articles by Marisa Wexler, MS
A protein called TIFA is elevated in the blood cells of people with pulmonary arterial hypertension (PAH), suggesting this…
An upcoming series of educational virtual events for people with pulmonary arterial hypertension (PAH) and their caregivers will offer…
Dosing has begun in a clinical trial testing AER-901, Aerami Therapeutics‘ inhaled formulation of imatinib, which is being investigated…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to PT001, an investigational treatment for pulmonary arterial…
A new metric for assessing cardiac health, called pulmonary artery proportional pulse pressure or PAPP, could help to identify people…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
Sandoz‘s generic treprostinil injection now is available for subcutaneous (under-the-skin) administration to treat pulmonary arterial hypertension (PAH), the…
A new analysis suggests that the doses of rodatristat ethyl — an investigational therapy for pulmonary arterial hypertension…
An updated application has been filed with the U.S. Food and Drug Administration (FDA), again asking that LIQ861Â be approved…
By screening thousands of potential candidates, researchers have identified a compound, called AG1296, that may be useful for the treatment of…
Activation of a protein called aryl hydrocarbon receptor (AHR) is essential for the development of pulmonary arterial hypertension (PAH),…